
Wedoctor
WeDoctor is an online healthcare services firm that runs online follow-up consultations, drug prescriptions and physician-staffed clinics.
- Company

WeDoctor is an online healthcare services firm that runs online follow-up consultations, drug prescriptions and physician-staffed clinics.
wedoctor.comCrawled Oct 25, 2026
Eleven Chinese healthcare and biotechnology firms filed for IPOs on the Hong Kong stock exchange in late September. We Doctor Holdings, a leading online healthcare services provider, joins Sichuan Biokin Pharmaceutical, which secured an $8.4 billion licensing agreement with Bristol Myers Squibb. Betta Pharmaceuticals, a profitable cancer-drug developer, also lists among the applicants, reflecting strong investor interest in the sector.
Oct 2025Yahoo FinanceNews article
WeDoctor, backed by Tencent Holdings, is restarting its Hong Kong IPO process after a 2021 filing was disrupted. The online healthcare platform plans to submit its application by the end of December, targeting a June completion and raising between **$400 million and $500 million**. The Hangzhou-based company specializes in digital healthcare services.
Dec 2024Yahoo FinanceNews article
WeDoctor, backed by Tencent, plans to file for an IPO in Hong Kong with a valuation nearing **US$7 billion** following its latest funding round. The company operates in the digital healthcare sector, leveraging its platform to connect patients with medical professionals. The upcoming IPO marks a significant milestone for the firm, which has grown under Tencent’s investment.
Feb 2021The Business TimesNews article
WeDoctor delays its Hong Kong initial public offering (IPO) to 2021 while targeting a valuation of **USD 10 billion**. The company had previously signaled plans for an IPO as early as May 2018, indicating ongoing preparations for a market listing.
Jul 2020EqualOceanNews article